Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists.

Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD.
Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope’s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.

Update: June, 2021:  Nanoscope Therapeutics Announces FDA Approval of IND for Phase 2b clinical trial of Optogenetic Gene Monotherapy to Restore Vision in Patients with Retinitis Pigmentosa




Health Care

Life Sciences

Medical Devices

Therapeutics

Nanoscope Therapeutics Inc.

Nanoscope Therapeutics Inc.'s headquarters in Dallas, United States

This department oversees the planning and execution of clinical trials and development of nonclinical research strategies.

Clinical Development

The Leadership Team at Nanoscope Therapeutics Inc. is responsible for steering the strategic direction of the company, ensuring the successful development and implementation of its groundbreaking gene therapies. This team oversees clinical trials, regulatory approvals, business development, financial management, and overall corporate strategy to achieve Nanoscope's mission of restoring vision in individuals suffering from retinal degenerative diseases.

Leadership Team

The Finance Team at Nanoscope Therapeutics Inc. oversees financial planning, budgeting, and reporting to ensure the company's resources are efficiently allocated towards their groundbreaking gene therapy research and clinical trials. This team, including the CFO and Accounting Manager, handles financial analysis, investor relations, regulatory compliance, and fiscal strategy, supporting the company's mission to develop innovative treatments for retinal degenerative diseases.

Finance Team

This department ensures that products meet quality standards through testing and evaluation processes.

Quality Assurance

This department supports organizational efficiency through management of office operations and administrative tasks.

Administrative Services

This department focuses on managing and overseeing investment portfolios and strategies.

��

People (3)

Jobs (0)

Other teams

Leadership Team

Finance Team

Quality Assurance

Administrative Services

Investment Management

��������

People (3)

Jobs (0)

Other teams

Leadership Team

Finance Team

Quality Assurance

Administrative Services

Investment Management

��